240 related articles for article (PubMed ID: 14982635)
41. Five-year surveillance of molecular markers of Plasmodium falciparum antimalarial drug resistance in Korogwe District, Tanzania: accumulation of the 581G mutation in the P. falciparum dihydropteroate synthase gene.
Alifrangis M; Lusingu JP; Mmbando B; Dalgaard MB; Vestergaard LS; Ishengoma D; Khalil IF; Theander TG; Lemnge MM; Bygbjerg IC
Am J Trop Med Hyg; 2009 Apr; 80(4):523-7. PubMed ID: 19346369
[TBL] [Abstract][Full Text] [Related]
42. Molecular surveillance of drug-resistance associated mutations of Plasmodium falciparum in south-west Tanzania.
Schönfeld M; Barreto Miranda I; Schunk M; Maduhu I; Maboko L; Hoelscher M; Berens-Riha N; Kitua A; Löscher T
Malar J; 2007 Jan; 6():2. PubMed ID: 17224049
[TBL] [Abstract][Full Text] [Related]
43. Molecular basis of antifolate resistance.
Assaraf YG
Cancer Metastasis Rev; 2007 Mar; 26(1):153-81. PubMed ID: 17333344
[TBL] [Abstract][Full Text] [Related]
44. Island-wide diversity in single nucleotide polymorphisms of the Plasmodium vivax dihydrofolate reductase and dihydropteroate synthetase genes in Sri Lanka.
Schousboe ML; Rajakaruna RS; Salanti A; Hapuarachchi HC; Galappaththy GN; Bygbjerg IC; Amerasinghe PH; Konradsen F; Alifrangis M
Malar J; 2007 Mar; 6():28. PubMed ID: 17349045
[TBL] [Abstract][Full Text] [Related]
45. Blood folate concentrations and in vivo sulfadoxine-pyrimethamine failure in Malawian children with uncomplicated Plasmodium falciparum malaria.
Dzinjalamala FK; Macheso A; Kublin JG; Taylor TE; Barnes KI; Molyneux ME; Plowe CV; Smith PJ
Am J Trop Med Hyg; 2005 Mar; 72(3):267-72. PubMed ID: 15772319
[TBL] [Abstract][Full Text] [Related]
46. High prevalence and fixation of Plasmodium vivax dhfr/dhps mutations related to sulfadoxine/pyrimethamine resistance in French Guiana.
Barnadas C; Musset L; Legrand E; Tichit M; Briolant S; Fusai T; Rogier C; Bouchier C; Picot S; Ménard D
Am J Trop Med Hyg; 2009 Jul; 81(1):19-22. PubMed ID: 19556560
[TBL] [Abstract][Full Text] [Related]
47. Probing the roles of non-homologous insertions in the N-terminal domain of Plasmodium falciparum hydroxymethylpterin pyrophosphokinase-dihydropteroate synthase.
Rattanachuen W; Jönsson M; Swedberg G; Sirawaraporn W
Mol Biochem Parasitol; 2009 Dec; 168(2):135-42. PubMed ID: 19631695
[TBL] [Abstract][Full Text] [Related]
48. MRP1 mediates folate transport and antifolate sensitivity in Plasmodium falciparum.
Rijpma SR; van der Velden M; Bilos A; Jansen RS; Mahakena S; Russel FG; Sauerwein RW; van de Wetering K; Koenderink JB
FEBS Lett; 2016 Feb; 590(4):482-92. PubMed ID: 26900081
[TBL] [Abstract][Full Text] [Related]
49. Assessment of the origins and spread of putative resistance-conferring mutations in Plasmodium vivax dihydropteroate synthase.
Hawkins VN; Suzuki SM; Rungsihirunrat K; Hapuarachchi HC; Maestre A; Na-Bangchang K; Sibley CH
Am J Trop Med Hyg; 2009 Aug; 81(2):348-55. PubMed ID: 19635897
[TBL] [Abstract][Full Text] [Related]
50. Molecular surveillance for drug-resistant Plasmodiumfalciparum malaria in Malawi.
Nkhoma S; Molyneux M; Ward S
Acta Trop; 2007 May; 102(2):138-42. PubMed ID: 17544355
[TBL] [Abstract][Full Text] [Related]
51. Rapid selection of dhfr mutant allele in Plasmodium falciparum isolates after the introduction of sulfadoxine/pyrimethamine in combination with 4-aminoquinolines in Papua New Guinea.
Mita T; Kaneko A; Hwaihwanje I; Tsukahara T; Takahashi N; Osawa H; Tanabe K; Kobayakawa T; Björkman A
Infect Genet Evol; 2006 Nov; 6(6):447-52. PubMed ID: 16600696
[TBL] [Abstract][Full Text] [Related]
52. Basis for antifolate action and resistance in malaria.
Yuthavong Y
Microbes Infect; 2002 Feb; 4(2):175-82. PubMed ID: 11880049
[TBL] [Abstract][Full Text] [Related]
53. Urban malaria in Dakar, Senegal: chemosusceptibility and genetic diversity of Plasmodium falciparum isolates.
Henry M; Diallo I; Bordes J; Ka S; Pradines B; Diatta B; M'Baye PS; Sane M; Thiam M; Gueye PM; Wade B; Touze JE; Debonne JM; Rogier C; Fusai T
Am J Trop Med Hyg; 2006 Jul; 75(1):146-51. PubMed ID: 16837722
[TBL] [Abstract][Full Text] [Related]
54. Relationship between age, molecular markers, and response to sulphadoxine-pyrimethamine treatment in Kampala, Uganda.
Staedke SG; Sendagire H; Lamola S; Kamya MR; Dorsey G; Rosenthal PJ
Trop Med Int Health; 2004 May; 9(5):624-9. PubMed ID: 15117308
[TBL] [Abstract][Full Text] [Related]
55. The molecular basis of folate salvage in Plasmodium falciparum: characterization of two folate transporters.
Salcedo-Sora JE; Ochong E; Beveridge S; Johnson D; Nzila A; Biagini GA; Stocks PA; O'Neill PM; Krishna S; Bray PG; Ward SA
J Biol Chem; 2011 Dec; 286(52):44659-68. PubMed ID: 21998306
[TBL] [Abstract][Full Text] [Related]
56. Virulence and drug resistance in malaria parasites.
Stein WD; Sanchez CP; Lanzer M
Trends Parasitol; 2009 Oct; 25(10):441-3. PubMed ID: 19734096
[TBL] [Abstract][Full Text] [Related]
57. [Molecular surveillance of sulfadoxine-pyrimethamine-resistant Plasmodium falciparum in São Tomé and Príncipe].
Tahar R; Djaman J; Ferreira C; Basco L
Bull Soc Pathol Exot; 2007 May; 100(2):115-8. PubMed ID: 17727034
[TBL] [Abstract][Full Text] [Related]
58. Resistance to antifolates in Plasmodium falciparum, the causative agent of tropical malaria.
Warhurst DC
Sci Prog; 2002; 85(Pt 1):89-111. PubMed ID: 11969121
[TBL] [Abstract][Full Text] [Related]
59. De novo and salvage biosynthesis of pteroylpentaglutamates in the human malaria parasite, Plasmodium falciparum.
Krungkrai J; Webster HK; Yuthavong Y
Mol Biochem Parasitol; 1989 Jan; 32(1):25-37. PubMed ID: 2643036
[TBL] [Abstract][Full Text] [Related]
60. Transcriptional analysis of genes encoding enzymes of the folate pathway in the human malaria parasite Plasmodium falciparum.
Nirmalan N; Wang P; Sims PF; Hyde JE
Mol Microbiol; 2002 Oct; 46(1):179-90. PubMed ID: 12366841
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
